Month: March 2022

Live webcast to be held March 31 discussing announcement VANCOUVER, Washington, March 30, 2022 (GLOBE NEWSWIRE) — CytoDyn Inc. (OTCQB: CYDY) (“CytoDyn” or the “Company”), a late-stage biotechnology company developing leronlimab, a CCR5 antagonist with the potential for multiple therapeutic indications, announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on its HIV program and a full clinical hold on its COVID-19 program in the United States. Further, the Company elected to pause its Brazil COVID-19 trials pending results from its previously scheduled data safety monitoring committee meeting and is in the process of reevaluating the timing of its HIV BLA resubmission. The Company was not enrolling any new patients in the trials placed on hold in the United States....

Figure 1: Cariboo deposit areas overview map Figure 1: Cariboo deposit areas overview mapFigure 2: Lowhee Zone select drilling highlights Figure 2: Lowhee Zone select drilling highlightsMONTREAL, March 30, 2022 (GLOBE NEWSWIRE) — Osisko Development Corp. (“Osisko Development” or the “Company”) (TSX.V-ODV) is pleased to announce drilling results from the 2021 exploration and category conversion drill campaign at its Cariboo Gold Project (“Cariboo”) in central British Columbia. SummaryA total of 29,450 meters were drilled in 94 holes at Lowhee Zone on Barkerville Mountain in 2021. Final assay results have now been received and this release include holes BM-21-081 to BM-21-094 (Figures 1 and 2). Drillhole BM-21-082 intersected multiple high-grade samples including 38.10 g/t Au over 0.50 meter, 70.00 g/t Au over 0.50 meter...

/NOT FOR DISTRIBUTION TO U.S. NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES./ BURLINGTON, Ontario, March 30, 2022 (GLOBE NEWSWIRE) — Anaergia Inc. (“Anaergia” or the “Company”) (TSX: ANRG) today announced that it has entered into an agreement to sell, on a bought deal basis, 4,800,000 subordinate voting shares (the “Shares”) at a price of $12.50 per Share (the “Issue Price”) to a syndicate of underwriters led by TD Securities Inc. (the “Underwriters”) for gross proceeds of approximately $60 million (the “Offering”). In addition, the Company has granted the Underwriters an over-allotment option (the “Over-Allotment Option”) to purchase up to an additional 720,000 Shares at the Issue Price, exercisable, in whole or in part, for a period of 30 days following closing of the Offering. If the Over-Allotment Option is exercised...

DETROIT, March 30, 2022 (GLOBE NEWSWIRE) — DT Midstream, Inc. (“DT Midstream” or the “Company”) (NYSE: DTM) today announced that it has priced an offering (the “Offering”) of $600,000,000 of 4.300% Senior Secured Notes due 2032 (the “Notes”). The Notes will be issued by DT Midstream, guaranteed by certain of DT Midstream’s subsidiaries and secured by a first priority lien on certain assets of DT Midstream and its subsidiary guarantors that secure DT Midstream’s existing credit facilities. The Offering is expected to close on April 11, 2022, subject to customary closing conditions. DT Midstream intends to use the net proceeds from the sale of the Notes to partially repay existing indebtedness under its term loan facility and expects the transaction to be leverage-neutral. The Notes are being sold in a private placement to persons...

This news release contains “forward-looking information and statements” within the meaning of applicable securities laws. For important information with respect to such forward-looking information and statements and the further assumptions and risks to which they are subject, see the “Cautionary Statement Regarding Forward-Looking Information and Statements” later in this news release. CALGARY, Alberta, March 30, 2022 (GLOBE NEWSWIRE) — Precision Drilling Corporation (“Precision” or the “Company”) (TSX:PD; NYSE:PDS) announces today the filing and publication of its Management Information Circular (the “Circular”) issued in connection with the 2022 Annual and Special Meeting of Shareholders (the “Annual Meeting”). Management Information Circular & Virtual-Only Annual Meeting Details Precision announces...

NEWS RELEASEMarch 30, 2022, 4:30 PM EST / 22:30 CET MDxHealth to Participate in the 14th Annual Kempen Life Sciences Conference IRVINE, CA, and HERSTAL, BELGIUM – March 30, 2022 – MDxHealth SA (NASDAQ/Euronext: MDXH), a commercial-stage precision diagnostics company, today announced that Michael K. McGarrity, CEO, will participate in the 14th Annual Kempen Life Sciences Conference which will take place in Amsterdam on April 20, 2022. The Company will be available for 1×1 meetings and invites investors to contact their Kempen representative for further information.2022 Updated Reporting CalendarApril 27, 2022: Q1-2022 business update May 25, 2022: Annual general shareholders’ meeting August 25, 2022: Publication of H1-2022 results October 27, 2022: Q3-2022 business updateAbout MDxHealth MDxHealth is a commercial-stage precision...